These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 27799773)
1. Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer. Zheng H; Li X; Chen C; Chen J; Sun J; Sun S; Jin L; Li J; Sun S; Wu X Int J Nanomedicine; 2016; 11():5519-5529. PubMed ID: 27799773 [TBL] [Abstract][Full Text] [Related]
2. [Relevance between TOP2A, EGFR gene expression and efficacy of docetaxel plus epirubicin as neoadjuvant chemotherapy in triple negative breast cancer patients]. Liu L; Li XR; Hu YH; Zhang J Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(12):940-3. PubMed ID: 27045718 [TBL] [Abstract][Full Text] [Related]
3. Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer. Zheng HM; Chen C; Wu XH; Chen J; Sun S; Sun JZ; Wang MW; Sun SR Tumour Biol; 2016 Feb; 37(2):2509-18. PubMed ID: 26385773 [TBL] [Abstract][Full Text] [Related]
4. Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer. Sun JZ; Chen C; Jiang G; Tian WQ; Li Y; Sun SR Int J Nanomedicine; 2014; 9():1339-46. PubMed ID: 24648732 [TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients). Eltohamy MI; Badawy OM; El kinaai N; Loay I; Nassar HR; Allam RM; Sakr MA Asian Pac J Cancer Prev; 2018 Dec; 19(12):3581-3589. PubMed ID: 30583686 [TBL] [Abstract][Full Text] [Related]
6. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer. Wu Y; Han Y; Li Q; Zhang P; Yuan P; Luo Y; Fan Y; Chen S; Cai R; Li Q; Xu H; Wang Y; Ma F; Wang J; Xu B Breast Cancer Res Treat; 2022 Jun; 193(2):381-392. PubMed ID: 35297009 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer. Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN Tumori; 2014; 100(1):80-6. PubMed ID: 24675496 [TBL] [Abstract][Full Text] [Related]
9. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer. Qiao JH; Jiao DC; Lu ZD; Yang S; Liu ZZ Tumour Biol; 2015 Sep; 36(9):6833-8. PubMed ID: 25846735 [TBL] [Abstract][Full Text] [Related]
11. Quantum dot-based immunofluorescent imaging and quantitative detection of DNER and prognostic value in prostate cancer. Wang L; Wu Q; Zhu S; Li Z; Yuan J; Liu L; Yu D; Xu Z; Li J; Sun S; Wang C Cancer Biomark; 2018; 22(4):683-691. PubMed ID: 29843212 [TBL] [Abstract][Full Text] [Related]
12. Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy. Nikolényi A; Uhercsák G; Csenki M; Hamar S; Csörgo E; Tánczos E; Thurzó L; Brodowicz T; Wagnerova M; Kahán Z Pathol Oncol Res; 2012 Jan; 18(1):61-8. PubMed ID: 21681601 [TBL] [Abstract][Full Text] [Related]
13. RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients. Xu YC; Zhang FC; Li JJ; Dai JQ; Liu Q; Tang L; Ma Y; Xu Q; Lin XL; Fan HB; Wang HX Oncol Rep; 2015 Oct; 34(4):1883-94. PubMed ID: 26252353 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of TOP2A as a Predictive Marker for Endometrial Cancer With Taxane-Containing Adjuvant Chemotherapy. Ito F; Furukawa N; Nakai T Int J Gynecol Cancer; 2016 Feb; 26(2):325-30. PubMed ID: 26588239 [TBL] [Abstract][Full Text] [Related]
15. Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status. Nielsen KV; Ejlertsen B; Møller S; Jensen MB; Balslev E; Müller S; Knoop A; Mouridsen HT Mol Oncol; 2012 Feb; 6(1):88-97. PubMed ID: 22153616 [TBL] [Abstract][Full Text] [Related]
16. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer. de Resende MF; Vieira S; Chinen LT; Chiappelli F; da Fonseca FP; Guimarães GC; Soares FA; Neves I; Pagotty S; Pellionisz PA; Barkhordarian A; Brant X; Rocha RM J Transl Med; 2013 Feb; 11():36. PubMed ID: 23398928 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer. An X; Xu F; Luo R; Zheng Q; Lu J; Yang Y; Qin T; Yuan Z; Shi Y; Jiang W; Wang S BMC Cancer; 2018 Mar; 18(1):331. PubMed ID: 29587760 [TBL] [Abstract][Full Text] [Related]
18. The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors. Panousis D; Patsouris E; Lagoudianakis E; Pappas A; Kyriakidou V; Voulgaris Z; Xepapadakis G; Manouras A; Athanassiadou AM; Athanassiadou P Eur J Gynaecol Oncol; 2011; 32(2):156-9. PubMed ID: 21614903 [TBL] [Abstract][Full Text] [Related]
19. Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas. Mrklić I; Spagnoli GC; Juretić A; Pogorelić Z; Tomić S Acta Histochem; 2014 Jun; 116(5):740-6. PubMed ID: 24560456 [TBL] [Abstract][Full Text] [Related]
20. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer. Rody A; Karn T; Ruckhäberle E; Müller V; Gehrmann M; Solbach C; Ahr A; Gätje R; Holtrich U; Kaufmann M Breast Cancer Res Treat; 2009 Feb; 113(3):457-66. PubMed ID: 18340528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]